National Cancer InstituteU.S. National Institutes of Healthwww.cancer.gov
Center to Reduce Cancer Health Disparities, Patient Navigation Program (PNP) logo

Chicago Cancer Navigation Project

  • PRINCIPAL INVESTIGATOR:

    Charles L. Bennett, M.D., Ph.D.

  • CO-PRINCIPAL INVESTIGATOR:

    Elizabeth Calhoun, Ph.D.

  • INSTITUTION:

    The Robert H. Lurie Comprehensive Cancer Center/Feinberg School of Medicine/Northwestern University

  • POPULATION SERVED:

    African American and Hispanic/Latino

Project Description

The Chicago Cancer Navigation Project will conduct a concerted intervention and evaluation of a patient navigation team consisting of a nurse, social worker, and lay navigator at a Veterans Affairs (VA) facility and five Federally Qualified Health Center (FQHC) clinics. Navigation will be provided to eligible patients with prostate, colorectal, breast or cervix abnormalities. The vast majority of participants will be members of racial or ethnic minorities; 75 percent will be African-American and 25 percent Hispanics/Latinos. The lay navigators will be trained and managed through a partnership with an existing program of the American Cancer Society. Time until resolution of abnormality, compliance with follow-up, and extensive patient characteristics and opinions will be compared with characteristics of a control group not receiving navigation services at another VA facility site and five FQHC clinics. Comparisons will also be made with historical group data.

Researchers and clinicians at Northwestern University, in partnership with the Jesse Brown VA Medical Center, the Access Community Health Network, and the American Cancer Society, aim to provide a patient navigation intervention that will: (1) increase the proportion of patients with diagnostic evaluations at intervention sites in comparison with usual care at control sites and past performance; (2) improve mean time to diagnostic resolution between abnormal screening and definitive follow-up; (3) significantly shorten the time to initiation of treatment following confirmatory diagnosis; (4) evaluate cost-effectiveness; (5) identify psychosocial and demographic factors associated with navigation non-compliance; and (6) assess patient satisfaction with the navigation experience.

Updated: 07/23/09